{"id":26365,"date":"2023-11-06T16:00:00","date_gmt":"2023-11-06T16:00:00","guid":{"rendered":"https:\/\/g-medtech.com\/news\/?p=26365"},"modified":"2026-07-23T10:34:07","modified_gmt":"2026-07-23T10:34:07","slug":"scott-drake-appointed-as-chief-executive-officer-of-cordis","status":"publish","type":"post","link":"https:\/\/g-medtech.com\/news\/scott-drake-appointed-as-chief-executive-officer-of-cordis\/","title":{"rendered":"Scott Drake Appointed as Chief Executive Officer of Cordis"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Scott Drake has been appointed Chief Executive Officer (CEO) of <a href=\"https:\/\/g-medtech.com\/database\/medtech-players\/index\/cordis\/\" target=\"_blank\" rel=\"noreferrer noopener\">Cordis<\/a> with immediate effect, succeeding Shar Matin who has stepped down as CEO.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mr. Drake has over 30 years of medical device experience including as the President and CEO of the Spectranetics Corporation, where he increased shareholder value from approximately $170 million to $2.2 billion during his six-year tenure. He has served on numerous boards of directors, including Zayo Group Holdings, which Digital Colony and EQT (EQT) acquired for $14.3 billion, Paragon 28, Inc. (FNA), ViewRay (VRAYQ), Bolder Surgical, the Medical Device Manufacturers Association (MDMA), and he has served as the Chairman of Atricure, Inc. (ATRC).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;I want to thank Shar for all he has done to stand Cordis up as an independent company. I have been on the Cordis Board of Directors for over two years, and I am thrilled to be taking on a more active role as CEO,&#8221; states Mr. Drake. &#8220;We are entering the next phase of the business, where Cordis is launching new products and driving a revolutionary business model with Cordis-X that will benefit our team, customers, patients, and shareholders.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scott Drake has been appointed Chief Executive Officer (CEO) of Cordis with immediate effect, succeeding Shar Matin who has stepped down as CEO.<\/p>\n","protected":false},"author":2,"featured_media":26366,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[10],"tags":[793],"class_list":["post-26365","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-strategic-development","tag-management"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/26365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/comments?post=26365"}],"version-history":[{"count":3,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/26365\/revisions"}],"predecessor-version":[{"id":40871,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/posts\/26365\/revisions\/40871"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media\/26366"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/media?parent=26365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/categories?post=26365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/wp-json\/wp\/v2\/tags?post=26365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}